These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 31331245)

  • 21. Public Acceptability of Gene Therapy and Gene Editing for Human Use: A Systematic Review.
    Delhove J; Osenk I; Prichard I; Donnelley M
    Hum Gene Ther; 2020 Jan; 31(1-2):20-46. PubMed ID: 31802714
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ethical issues of CRISPR technology and gene editing through the lens of solidarity.
    Mulvihill JJ; Capps B; Joly Y; Lysaght T; Zwart HAE; Chadwick R;
    Br Med Bull; 2017 Jun; 122(1):17-29. PubMed ID: 28334154
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ethics of Human Genome Editing.
    Coller BS
    Annu Rev Med; 2019 Jan; 70():289-305. PubMed ID: 30691366
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulating germline editing in assisted reproductive technology: An EU cross-disciplinary perspective.
    Nordberg A; Minssen T; Feeney O; de Miguel Beriain I; Galvagni L; Wartiovaara K
    Bioethics; 2020 Jan; 34(1):16-32. PubMed ID: 31877579
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Crispr Future for Gene-Editing Regulation: a Proposal for an Updated Biotechnology Regulatory System in an Era of Human Genomic Editing.
    Tomlinson T
    Fordham Law Rev; 2018 Oct; 87(1):437-83. PubMed ID: 30296034
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ethics and regulatory considerations for the clinical translation of somatic cell human epigenetic editing.
    Zeps N; Lysaght T; Chadwick R; Erler A; Foo R; Giordano S; San Lai P; Schaefer GO; Xafis V; Chew WL; Sugarman J
    Stem Cell Reports; 2021 Jul; 16(7):1652-1655. PubMed ID: 34214486
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Legal issues regarding gene editing at the beginning of life: an EU perspective.
    De Miguel Beriain I
    Regen Med; 2017 Sep; 12(6):669-679. PubMed ID: 28976851
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Attitudes of Members of Genetics Professional Societies Toward Human Gene Editing.
    Armsby AJ; Bombard Y; Garrison NA; Halpern-Felsher BL; Ormond KE
    CRISPR J; 2019 Oct; 2(5):331-339. PubMed ID: 31599688
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human Genome Editing and Ethical Considerations.
    Krishan K; Kanchan T; Singh B
    Sci Eng Ethics; 2016 Apr; 22(2):597-9. PubMed ID: 26154417
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Wisdom of Germline Editing: An Ethical Analysis of the Use of CRISPR-Cas9 to Edit Human Embryos.
    Gumer JM
    New Bioeth; 2019 Jun; 25(2):137-152. PubMed ID: 31130112
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genome Editing: Past, Present, and Future.
    Carroll D
    Yale J Biol Med; 2017 Dec; 90(4):653-659. PubMed ID: 29259529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Science and Bioethics of CRISPR-Cas9 Gene Editing: An Analysis Towards Separating Facts and Fiction.
    Cribbs AP; Perera SMW
    Yale J Biol Med; 2017 Dec; 90(4):625-634. PubMed ID: 29259526
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ethical and regulatory aspects of genome editing.
    Kohn DB; Porteus MH; Scharenberg AM
    Blood; 2016 May; 127(21):2553-60. PubMed ID: 27053531
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blurring the germline: Genome editing and transgenerational epigenetic inheritance.
    Lewens T
    Bioethics; 2020 Jan; 34(1):7-15. PubMed ID: 31264238
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Focusing on Human Rights: a framework for CRISPR germline genome editing ethics and regulation.
    Doxzen K; Halpern J
    Perspect Biol Med; 2020; 63(1):44-53. PubMed ID: 32063585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Germline Modification and Policymaking: The Relationship between Mitochondrial Replacement and Gene Editing.
    Cussins J; Lowthorp L
    New Bioeth; 2018 Apr; 24(1):74-94. PubMed ID: 29529982
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adopt a moratorium on heritable genome editing.
    Lander ES; Baylis F; Zhang F; Charpentier E; Berg P; Bourgain C; Friedrich B; Joung JK; Li J; Liu D; Naldini L; Nie JB; Qiu R; Schoene-Seifert B; Shao F; Terry S; Wei W; Winnacker EL
    Nature; 2019 Mar; 567(7747):165-168. PubMed ID: 30867611
    [No Abstract]   [Full Text] [Related]  

  • 38. [The Washington summit: orange light for genome editing?].
    Jordan B
    Med Sci (Paris); 2016 Feb; 32(2):217-20. PubMed ID: 26936181
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ethical and regulatory issues in human gene editing: Chinese perspective.
    Lei R; Qiu R
    Biotechnol Appl Biochem; 2020 Nov; 67(6):880-891. PubMed ID: 33011985
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Building Capacity for a Global Genome Editing Observatory: Conceptual Challenges.
    Hurlbut JB; Jasanoff S; Saha K; Ahmed A; Appiah A; Bartholet E; Baylis F; Bennett G; Church G; Cohen IG; Daley G; Finneran K; Hurlbut W; Jaenisch R; Lwoff L; Kimes JP; Mills P; Moses J; Park BS; Parens E; Salzman R; Saxena A; Simmet H; Simoncelli T; Snead OC; Rajan KS; Truog RD; Williams P; Woopen C
    Trends Biotechnol; 2018 Jul; 36(7):639-641. PubMed ID: 29871776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.